Company / Financials
MEDIFAST INC Financials
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$385.8M
FY2025 · -36.0% YoY
Net Income
-$18.7M
FY2025 · -993.0% YoY
Profit Margin
-4.8%
FY2025 · net income / revenue
ROE
-9.4%
FY2025 · return on equity
Total Assets
$248.0M
FY2025
Total Debt
-
FY2025
Equity
$198.9M
FY2025
ROA
-7.5%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score 4.08 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$385.8M-36.0% YoYNet Income HistoryProfit after all expenses and taxes-$18.7M-993.0% YoYGross Profit HistoryRevenue minus cost of goods sold$275.2M-38.1% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$110.6M-29.9% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$14.2M-593.8% YoYSG&A Expense HistorySelling, general, and administrative expenses$289.4M-34.5% YoYR&D Expense HistoryResearch and development spending$4.3M-6.5% YoYInterest Expense HistoryCost of borrowing and debt obligations$89.0KIncome Tax HistoryTotal income tax expense$13.0M+668.5% YoYEPS (Basic) HistoryBasic earnings per share$9.13-28.8% YoY